PMV PHARMACEUTICALS, INC. Capital Expenditures
PMV PHARMACEUTICALS, INC. (PMVP) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14
- PMV PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- PMV PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- PMV PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $15.00K, a 73.21% decline year-over-year.
- PMV PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was -$1.00K, a 200.00% decline year-over-year.
- PMV PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $29.00K, a 95.57% decline from fiscal 2024.
- PMV PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $655.00K, a 31.91% decline from fiscal 2023.
- PMV PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $962.00K, a 87.95% decline from fiscal 2022.
- PMV PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $7.98M, a 491.85% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $15.00K derived: sum of 3 quarters · filed 2026-08-14 | $14.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $15.00K derived: sum of 2 quarters · filed 2026-05-12 | $14.00K derived: sum of 3 quarters · filed 2026-05-12 | $25.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $14.00K derived: sum of 2 quarters · filed 2026-03-06 | $25.00K derived: sum of 3 quarters · filed 2026-08-14 | $29.00K 10-K · filed 2026-03-06 |
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $10.00K derived: sum of 2 quarters · filed 2026-08-14 | $14.00K 10-Q · filed 2025-11-12 | $70.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $15.00K 10-Q · filed 2026-08-14 | $71.00K derived: sum of 3 quarters · filed 2026-08-14 | $72.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-12 | $60.00K derived: sum of 2 quarters · filed 2026-05-12 | $61.00K derived: sum of 3 quarters · filed 2026-05-12 | $65.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $57.00K derived: sum of 2 quarters · filed 2026-03-06 | $61.00K derived: sum of 3 quarters · filed 2026-03-06 | $655.00K 10-K · filed 2026-03-06 |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $5.00K derived: sum of 2 quarters · filed 2025-11-12 | $599.00K 10-Q · filed 2025-11-12 | $796.00K derived: sum of 4 quarters · filed 2026-03-06 |
| 2024-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $598.00K 10-Q · filed 2025-08-07 | $795.00K derived: sum of 3 quarters · filed 2026-03-06 | $839.00K derived: sum of 4 quarters · filed 2026-03-06 |
| 2024-03-31 | $594.00K 10-Q · filed 2025-05-09 | $791.00K derived: sum of 2 quarters · filed 2026-03-06 | $835.00K derived: sum of 3 quarters · filed 2026-03-06 | $1.40M derived: sum of 4 quarters · filed 2026-03-06 |
| 2023-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $241.00K derived: sum of 2 quarters · filed 2026-03-06 | $806.00K derived: sum of 3 quarters · filed 2026-03-06 | $962.00K 10-K · filed 2026-03-06 |
| 2023-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $609.00K derived: sum of 2 quarters · filed 2024-11-07 | $765.00K 10-Q · filed 2024-11-07 | $2.40M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $565.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $721.00K 10-Q · filed 2024-08-08 | $2.36M derived: sum of 3 quarters · filed 2025-03-03 | $4.41M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $156.00K 10-Q · filed 2024-05-09 | $1.79M derived: sum of 2 quarters · filed 2025-03-03 | $3.84M derived: sum of 3 quarters · filed 2025-03-03 | $7.34M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $3.69M derived: sum of 2 quarters · filed 2025-03-03 | $7.19M derived: sum of 3 quarters · filed 2025-03-03 | $7.98M 10-K · filed 2025-03-03 |
| 2022-09-30 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.55M derived: sum of 2 quarters · filed 2023-11-09 | $6.35M 10-Q · filed 2023-11-09 | $6.61M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $4.30M 10-Q · filed 2023-08-09 | $4.56M derived: sum of 3 quarters · filed 2024-02-29 | $5.06M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $796.00K 10-Q · filed 2023-05-10 | $1.06M derived: sum of 2 quarters · filed 2024-02-29 | $1.56M derived: sum of 3 quarters · filed 2024-02-29 | $2.02M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $262.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $763.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.23M derived: sum of 3 quarters · filed 2024-02-29 | $1.35M 10-K · filed 2024-02-29 |
| 2021-09-30 | $501.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $967.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.09M 10-Q · filed 2022-11-08 | $1.14M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $466.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $586.00K 10-Q · filed 2022-08-09 | $643.00K derived: sum of 3 quarters · filed 2023-03-01 | $683.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $120.00K 10-Q · filed 2022-05-10 | $177.00K derived: sum of 2 quarters · filed 2023-03-01 | $217.00K derived: sum of 3 quarters · filed 2023-03-01 | $217.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $97.00K derived: sum of 2 quarters · filed 2023-03-01 | $97.00K derived: sum of 3 quarters · filed 2023-03-01 | $148.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $40.00K derived: sum of 2 quarters · filed 2021-11-12 | $91.00K 10-Q · filed 2021-11-12 | $91.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $51.00K 10-Q · filed 2021-08-13 | $51.00K derived: sum of 3 quarters · filed 2022-03-01 | |
| 2020-03-31 | $51.00K 10-Q · filed 2021-05-14 | $51.00K derived: sum of 2 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $109.00K 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $109.00K 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $452.00K 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |